Correction: ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer

期刊论文
出版模式：

开放获取
发表日期：

2024年7月29日

查看全文

Alexandra Leary,
Purificación Estévez-García,
Renaud Sabatier,
Isabelle Ray-Coquard,
Margarita Romeo,
Pilar Barretina-Ginesta,
Marta Gil-Martin,
Elena Garralda,
Joaquim Bosch-Barrera,
Teresa Morán,
Paloma Martin-Martorell,
Ernest Nadal,
Pere Gascón,
Jordi Rodon,
Jose M Lizcano,
Pau Muñoz-Guardiola,
Gemma Fierro-Durán,
Oriol Pedrós-Gámez,
Héctor Pérez-Montoyo,
Marc Yeste-Velasco,
Marc Cortal,
Antonio Pérez-Campos,
Jose Alfon,
Carles Domenech,
Alejandro Pérez-Fidalgo,
Ana Oaknin

本文未提供摘要，请点击“查看全文”查看完整内容。